Purified Cortrophin Gel Now Available for Certain Chronic Autoimmune Disorders
The product is available through a network of specialty pharmacies and distributors.
Multiple Sclerosis
Epstein-Barr Virus Suspected as Cause of Multiple Sclerosis
Risk for MS increased 32-fold following EBV infection, but not following infection with other viruses, including cytomegalovirus
Ublituximab Under Review for Relapsing Forms of Multiple Sclerosis
Ublituximab is an investigational glycoengineered monoclonal antibody that targets CD20.
Further Study Needed for Teriflunomide in Children With Relapsing MS
No difference seen between teriflunomide and placebo groups for primary end point of time to first confirmed clinical relapse
Lyvispah Oral Granules Approved for Spasticity Due to Multiple Sclerosis
Lyvispah is supplied as a strawberry-flavored, dissolvable granular formulation of baclofen.
FDA Approves Cortrophin Gel for Certain Chronic Autoimmune Disorders
Cortrophin Gel is a purified adrenocorticotropic hormone.
Pepaxto Withdrawn from US Market Following OCEAN Trial Results
The phase 3 OCEAN study evaluated Pepaxto in combination with low-dose dexamethasone in adults with relapsed or refractory multiple myeloma following 2 to 4 lines of prior therapy and who were refractory to lenalidomide in the last line of therapy.
Ublituximab BLA Submitted for Relapsing Forms of Multiple Sclerosis
Ublituximab is an investigational glycoengineered anti-CD20 monoclonal antibody.
MS Patients Show Robust T-Cell Response to mRNA COVID-19 Vaccines
MS patients receiving anti-CD20 monoclonal antibody treatment can still mount T-cell responses
FDA to Review sNDA for Purified Cortrophin Gel for Multiple Indications
Purified Cortrophin Gel is a purified adrenocorticotropic hormone.
